Evaluation Process

As of November 16, 2018, Blood System Products (BSPs) will be evaluated on an ongoing basis rather than on set dates, and requests can be submitted at any time. However, manufacturers will still be required to provide advance notice two months before the date on which they submit their request.

Moreover, as of the above date, it will be necessary to use a new submission form when filing a request.